Labeling architecture in a regulated medical device company: strategy, content reuse, and complexities to be addressed

Abstract

This project explores labeling architecture in a regulated industry. Specifically, I explored ways to develop strategy for effective architecture of a product or therapy’s suite of labeling pieces, why labeling architecture is important for content reuse, and what complexities should be addressed during analysis and planning. I begin by noting the subtle difference that exists between a label and labeling. I then discuss labeling architecture as it relates to current work in technical communication on content architecture and information architecture, finding that labeling architecture often limits the number of times a manual needs to be updated, promotes content reuse (crucial for effective technical writing), limits human error, and reduces costs. To investigate labeling architecture, I conducted a set of six interviews to collect information on the strategy behind labeling architecture, how it supports content reuse, and complexities to be addressed during a labeling architecture project. Attention to labeling architecture could well be an effective way for a medical device company to save money and time, and increase the quality of their labeling products.